Treatment Duration in Patients With Transplant-Ineligible NDMM

Shared perspectives on the role of continued therapy in patients with transplant-ineligible newly diagnosed multiple myeloma in light of clinical data and dose adjustment strategies.

Related Videos
Noa Biran, MD, an expert on multiple myeloma
Experts on multiple myeloma
Experts on GVHD with a patient
Experts on GVHD with a patient
Experts on RCC
Experts on RCC
Experts on multiple myeloma
Experts on multiple myeloma
Related Content